Acerca deEmpresas
AyudaPrivacidadTérminos
ResumenLegal y estadoLínea temporalRedPropiedad y gestiónAccionistasBeneficiario finalGeografíaFinanzasSalud financieraDocumentos
ResumenLegal y estadoLínea temporalRedPropiedad y gestiónAccionistasBeneficiario finalGeografíaFinanzasSalud financieraDocumentos

SPANSWICK LTD

🇬🇧Reino Unido•Private Limited Company (Ltd.)•Activa

Resumen

País🇬🇧Reino Unido
EstadoActiva
Número de registro08331757
Fundada14/12/2012
Objeto socialInformation technology consultancy activities
DirecciónWsp House, 70 Chancery Lane, London, WC2A 1AF
Declaración de confirmaciónPróximo vencimiento: —; Última elaboración: —

Legal y estado

Forma legalPrivate Limited Company (Ltd.)
EstadoActiva
Fecha de registro14/12/2012
Autoridad registralCompanies House
Capital registrado2 GBP

Fuente: UK Companies House · Última actualización: 2/12/2025

Línea temporal (35 eventos)

17/5/2026

Dirección actualizada

Wsp House, 70 Chancery Lane

1/2/2026

Dirección actualizada

Wsp House, 70, Chancery Lane

14/12/2012

Nombramiento Jonathan Reeve (persona)

Nombrado como Director

Red

Este diagrama tiene muchas conexiones. para una mejor experiencia.
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Profundidad de la red

Propiedad y gestión

Persons with significant control

Lexica Health And Life Sciences Consultancy Limited

75–100% shares · 75–100% voting rights · Right to appoint directors

Nombrado el: 23/4/2025

87.5%
Jonathan Reeve

50–75% shares · 50–75% voting rights · 75–100% voting rights · Right to appoint directors

Nombrado el: 30/6/2016 · Dimitió el: 23/4/2025

62.5%
Vanessa Reeve

25–50% shares · 25–50% voting rights

Nombrado el: 6/4/2016 · Dimitió el: 31/3/2024

37.5%

Officers & directors

Paul Reilly

Director

Nombrado el: 30/5/2025

—
Miles Lawrence Barnard

Director

Nombrado el: 30/5/2025

—

Mostrando 1–5 de 10

1 / 2

Línea temporal de propiedad (6 cambios)

23/4/2025

Nombramiento Lexica Health And Life Sciences Consultancy Limited (empresa)

owns or controls

23/4/2025

Baja Jonathan Reeve (persona)

Persona con control significativo

6/4/2016

Nombramiento Jonathan Reeve (persona)

Persona con control significativo

Accionistas

NombreParticipaciónVotoDesde
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Beneficiario final

NombreParticipaciónPaísDesde
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Geografía

Sede

Wsp House

70 Chancery Lane

London

WC2A 1AF

Finanzas

Cifras clave de cuentas anuales.

Convertir a

2013

Beneficio / (pérdida): £31.5K

Cifras clave

Beneficio / (pérdida)

2013£31.497
2014£31.497
2015£79.811
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Activo total

2013£31.498
2014£31.498
2015£79.812
2016£76.648
2017£86.229
2018£86.229
2019£95.200
2022£171.938
2023£151.294
2024£144.453

Net Assets Liabilities

2013—
2014—
2015—
2016£66.259
2017—
2018£86.229
2019£95.200
2022£171.938
2023£151.294
2024£144.453

Equity

2013—
2014—
2015—
2016£66.259
2017—
2018£86.229
2019£95.200
2022£171.938
2023£151.294
2024£144.453

Current Assets

2013£77.581
2014£77.581
2015£109.926
2016£101.097
2017£110.548
2018£110.548
2019£128.369
2022£211.063
2023£193.383
2024£196.412

Net Current Assets Liabilities

2013£30.789
2014£30.789
2015£79.211
2016£79.321
2017£86.628
2018£86.628
2019£97.428
2022£175.250
2023£153.791
2024£144.356

Total Assets Less Current Liabilities

2013£31.675
2014£31.675
2015£79.962
2016£79.940
2017£88.555
2018£88.555
2019£99.095
2022£178.468
2023£156.346
2024£148.691

Debtors

2013£60.839
2014£60.839
2015£681
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Creditors

2013—
2014—
2015—
2016£17.235
2017—
2018£25.030
2019£31.980
2022£58.132
2023£41.606
2024£74.054

Number Shares Allotted

2013100
20141
2015100
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Par Value Share

2013£0
2014£1
2015£0
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Average Number Employees During Period

2013—
2014—
2015—
2016—
2017—
20181
20191
20221
20231
20243

Accruals Deferred Income

2013—
2014—
2015—
2016£3292
2017£2326
2018—
2019—
2022—
2023—
2024—

Accrued Liabilities Not Expressed Within Creditors Subtotal

2013—
2014—
2015—
2016£2048
2017—
2018£2326
2019£3895
2022£6530
2023£5052
2024£4238

Called Up Share Capital

2013£1
2014£1
2015£1
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Cash Bank In Hand

2013£16.742
2014£16.742
2015£109.245
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Creditors Due Within One Year

2013£46.792
2014£46.792
2015£30.715
2016£22.801
2017£25.030
2018—
2019—
2022—
2023—
2024—

Fixed Assets

2013£886
2014£886
2015£751
2016£619
2017£1927
2018£1927
2019£1667
2022£3218
2023£2555
2024£4335

Net Assets Liabilities Including Pension Asset Liability

2013£31.498
2014£31.498
2015£79.812
2016£76.648
2017£86.229
2018—
2019—
2022—
2023—
2024—

Prepayments Accrued Income Not Expressed Within Current Asset Subtotal

2013—
2014—
2015—
2016£1025
2017£1110
2018£1110
2019£1039
2022£22.319
2023£2014
2024£21.998

Profit Loss Account Reserve

2013£31.497
2014£31.497
2015£79.811
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Provisions For Liabilities Charges

2013£177
2014£150
2015£161
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Share Capital Allotted Called Up Paid

2013£1
2014£1
2015£1
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Shareholder Funds

2013£31.498
2014£31.498
2015£79.812
2016£76.648
2017£86.229
2018—
2019—
2022—
2023—
2024—

Tangible Fixed Assets

2013£886
2014£886
2015£751
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Tangible Fixed Assets Additions

2013£1145
2014£208
2015£438
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Tangible Fixed Assets Cost Or Valuation

2013£1145
2014£1353
2015£1791
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Tangible Fixed Assets Depreciation

2013£259
2014£602
2015£982
2016—
2017—
2018—
2019—
2022—
2023—
2024—

Tangible Fixed Assets Depreciation Charged In Period

2013£259
2014£343
2015£380
2016—
2017—
2018—
2019—
2022—
2023—
2024—
Métrica2013201420152016201720182019202220232024
Beneficio / (pérdida)£31.497£31.497£79.811———————
Activo total£31.498£31.498£79.812£76.648£86.229£86.229£95.200£171.938£151.294£144.453
Net Assets Liabilities———£66.259—£86.229£95.200£171.938£151.294£144.453
Equity———£66.259—£86.229£95.200£171.938£151.294£144.453
Current Assets£77.581£77.581£109.926£101.097£110.548£110.548£128.369£211.063£193.383£196.412
Net Current Assets Liabilities£30.789£30.789£79.211£79.321£86.628£86.628£97.428£175.250£153.791£144.356
Total Assets Less Current Liabilities£31.675£31.675£79.962£79.940£88.555£88.555£99.095£178.468£156.346£148.691
Debtors£60.839£60.839£681———————
Creditors———£17.235—£25.030£31.980£58.132£41.606£74.054
Number Shares Allotted1001100———————
Par Value Share£0£1£0———————
Average Number Employees During Period—————11113
Accruals Deferred Income———£3292£2326—————
Accrued Liabilities Not Expressed Within Creditors Subtotal———£2048—£2326£3895£6530£5052£4238
Called Up Share Capital£1£1£1———————
Cash Bank In Hand£16.742£16.742£109.245———————
Creditors Due Within One Year£46.792£46.792£30.715£22.801£25.030—————
Fixed Assets£886£886£751£619£1927£1927£1667£3218£2555£4335
Net Assets Liabilities Including Pension Asset Liability£31.498£31.498£79.812£76.648£86.229—————
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal———£1025£1110£1110£1039£22.319£2014£21.998
Profit Loss Account Reserve£31.497£31.497£79.811———————
Provisions For Liabilities Charges£177£150£161———————
Share Capital Allotted Called Up Paid£1£1£1———————
Shareholder Funds£31.498£31.498£79.812£76.648£86.229—————
Tangible Fixed Assets£886£886£751———————
Tangible Fixed Assets Additions£1145£208£438———————
Tangible Fixed Assets Cost Or Valuation£1145£1353£1791———————
Tangible Fixed Assets Depreciation£259£602£982———————
Tangible Fixed Assets Depreciation Charged In Period£259£343£380———————

Documentos

Confirmation statement

16/12/2025

Ver

Current accounting period extended from 30 September 2025 to 31 December 2025

23/9/2025

Ver

Appointment of director

11/6/2025

Ver

Appointment of director

11/6/2025

Ver

Change of registered office address

11/6/2025

Ver

Appointment of secretary

11/6/2025

Ver

IA de documentos

Próximamente

Companexia Document AI

Haga preguntas sobre presentaciones y extractos—nuestra IA leerá los documentos y responderá en contexto.

Termination of director appointment

11/6/2025

Ver

Cessation as person with significant control

6/5/2025

Ver

Cessation as person with significant control

6/5/2025

Ver

Mostrando 1–10 de 51

1 / 6

Explorar más empresas y personas

🇮🇪KILDALE LIMITED🇮🇪BRAMBURY LIMITED🇮🇪AVONMOUNT LIMITEDNicolas Ordonez ManriqueSYLVIE CHRISTIANE RETORE🇬🇧Mrs Sarah Jane Savage
Ratio de liquidez corriente (2017)Ratio de liquidez corriente
4,42×
Pasivos / fondos propios (2016)Pasivos / fondos propios
0,16×
Beneficio / (pérdida) interanual (2014 vs. 2015)Beneficio / (pérdida) interanual
+153,4 %
Rentabilidad sobre activos (neta) (2015)Rentabilidad sobre activos (neta)
100 %
Pasivos / activos totales (2016)Pasivos / activos totales
13,6 %

Salud financiera

Ratios derivados de las cuentas anuales. Se omiten los valores cuando faltan datos o no son significativos.

Crecimiento

Beneficio / (pérdida) interanual (2014 vs. 2015)
+153,4 %
Activos totales interanuales (2014 vs. 2015)
+153,4 %
Activo circulante neto interanual (2014 vs. 2015)
+157,3 %
Activos totales interanuales (2015 vs. 2016)
-4 %
Activo circulante neto interanual (2015 vs. 2016)
+0,1 %
Activos totales interanuales (2016 vs. 2017)
+12,5 %
Activo circulante neto interanual (2016 vs. 2017)
+9,2 %
Activos totales interanuales (2018 vs. 2019)
+10,4 %
Activo circulante neto interanual (2018 vs. 2019)
+12,5 %
Activos totales interanuales (2019 vs. 2022)
+80,6 %
Activo circulante neto interanual (2019 vs. 2022)
+79,9 %
Activos totales interanuales (2022 vs. 2023)
-12 %
Activo circulante neto interanual (2022 vs. 2023)
-12,2 %
Activos totales interanuales (2023 vs. 2024)
-4,5 %
Activo circulante neto interanual (2023 vs. 2024)
-6,1 %
CAGR activos totales (2013–2024)
+18,4 %

Eficiencia y rentabilidad

Rentabilidad sobre activos (neta) (2013)
100 %
Rentabilidad sobre activos (neta) (2014)
100 %
Rentabilidad sobre activos (neta) (2015)
100 %

Capital circulante y liquidez

Ratio de liquidez corriente (2013)
1,66×
Activo circulante neto (2013)
30.789 GBP
Ratio de liquidez corriente (2014)
1,66×
Activo circulante neto (2014)
30.789 GBP
Ratio de liquidez corriente (2015)
3,58×

Estructura de capital

Ratio de fondos propios (2016)
86,4 %
Pasivos / activos totales (2016)
13,6 %
Pasivos / fondos propios (2016)
0,16×
Ratio de fondos propios (2018)
100 %
Ratio de fondos propios (2019)
100 %
Ratio de fondos propios (2022)
100 %
  1. Inicio
  2. –Reino Unido
  3. –London
  4. –SPANSWICK LTD
Activo circulante neto (2015)
79.211 GBP
Ratio de liquidez corriente (2016)
4,43×
Activo circulante neto (2016)
79.321 GBP
Ratio de liquidez corriente (2017)
4,42×
Activo circulante neto (2017)
86.628 GBP
Activo circulante neto (2018)
86.628 GBP
Activo circulante neto (2019)
97.428 GBP
Activo circulante neto (2022)
175.250 GBP
Activo circulante neto (2023)
153.791 GBP
Activo circulante neto (2024)
144.356 GBP
Ratio de fondos propios (2023)
100 %
Ratio de fondos propios (2024)
100 %